Skip to content
GLEN Industries logo

GLEN Industries

544444 BSE
₹108.10

Close ·

P/E
22.52
View as Markdown
MCP
Close 4 Nov 2026 ₹108.10 +32.10 +42.2% 1Y
Start ₹76.00

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · TTM

ROCE
13.80%
Debt to Equity
0.87
EPS (TTM)
₹4.80
Book Value
₹54.64
Market Cap
—
P/E (TTM)
22.52
P/B
1.98
ROE
16.60%
Dividend Yield
0.00%
EBITDA
₹39.10 Cr
52W High
₹134.00
52W Low
₹58.00

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

51 Average

Data confidence 98/100

Category scores

Quality
46
Average
Returns, margins, earnings quality 22% weight
Valuation
37
Poor
Cheap vs sector & own history 24% weight
Growth
68
Strong
Sales & profit trajectory 9% weight
Financial Health
42
Weak
Solvency, leverage, coverage 9% weight
Momentum
97
Strong
Trend strength, vol-adjusted 12% weight
Ownership
51
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Promoter holding has increased by 0.99% over last quarter.

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish568
OscillatorsBearish261
Moving AveragesStrong Bullish307

Key readings

RSI (14)
47.87
Neutral
MACD (12,26,9)
−3.39
Bullish
SMA (50)
116.85
Bearish
SMA (200)
86.66
Bullish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
3Y+20.06%
1Y+19.88%

Net profit

Net profit growth by window
3Y+151.98%
1Y−11.11%

Operating cash flow

Operating cash flow growth by window
3Y−18.29%
1Y0.00%

Operating margin· change in pp

Operating margin growth by window
3Y+4.68 pp
1Y−5.51 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹92.00 Cr
Mar 2023₹115 Cr
Mar 2024₹140 Cr
Mar 2025₹166 Cr
Mar 2026₹199 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022₹4.00 Cr
Mar 2023₹1.00 Cr
Mar 2024₹9.00 Cr
Mar 2025₹18.00 Cr
Mar 2026₹16.00 Cr

Half-yearly Results

₹ Cr
544444 half-yearly results, ₹ crore
Particulars Sep 2024Mar 2025Sep 2025Mar 2026
Sales
84
87
96
108
Expenses
66
64
76
90
Operating Profit
18
23
19
18
OPM %
21%
26%
20%
17%
Other Income
1
0
1
1
Interest
4
6
5
5
Depreciation
4
4
4
4
PBT
11
13
11
11
Tax %
25%
26%
25%
23%
Net Profit
8
10
8
8
EPS (₹)
4.84
5.53
3.45
3.41

Profit & Loss

₹ Cr
544444 profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
92
115
140
166
199
Expenses
81
99
115
126
162
Operating Profit
11
16
25
40
37
OPM %
12%
14%
18%
24%
19%
Other Income
3
−2
0
1
2
Interest
4
6
7
9
9
Depreciation
5
6
6
7
8
PBT
5
3
11
24
22
Tax %
27%
44%
25%
25%
24%
Net Profit
4
1
9
18
16
EPS (₹)
2.09
0.85
4.84
10.37
6.86
Div. Payout %
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
544444 balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
18
32
Reserves
17
31
40
41
107
Borrowings
77
86
94
133
121
Other Liabilities
22
19
26
23
30
Total Liabilities
116
137
161
214
291
Fixed Assets
55
73
81
108
108
CWIP
1
0
0
1
12
Investments
0
0
0
0
0
Other Assets
60
64
80
106
170
Total Assets
116
137
161
214
291

Cash Flow

₹ Cr
544444 cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−14
11
14
6
6
Investing
−22
−15
−13
−35
−18
Financing
34
4
−2
30
11
Net Cash Flow
−2
0
−1
1
−1
Free Cash Flow
−29
−2
0
−29
−14
CFO/EBITDA
−124
75
57
20
32

Ratios

544444 financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
61
52
69
68
68
Inventory Days
192
192
184
252
240
Days Payable
34
42
51
25
41
Cash Conversion Cycle
219
202
203
294
267
Working Capital Days
6
−6
4
4
25
ROCE %
—
10%
15%
20%
14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view GLEN Industries insights

51 extracted metrics across FY22–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 74.30%
  • Public 15.50%
  • DIIs 6.01%
  • Others 4.19%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about GLEN Industries

What does GLEN Industries Ltd do?
Incorporated in 2007, Glen Industries Limited (GIL) is engaged in the manufacturing of eco-friendly food packaging and service products.
Where is GLEN Industries Ltd (GLEN) listed?
GLEN Industries Ltd trades under code 544444 on the BSE.
Which sector does GLEN Industries Ltd belong to?
GLEN Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of GLEN Industries Ltd?
GLEN Industries Ltd trades at a PE ratio of 22.52 as of 4 Nov 2026, on earnings per share of ₹4.8, against a book value of ₹54.64 per share.
What is the 52-week high and low of GLEN Industries Ltd?
Over the last 52 weeks GLEN Industries Ltd has traded between ₹58 and ₹134 as of 4 Nov 2026.
What is the Return on Equity (ROE) of GLEN Industries Ltd?
GLEN Industries Ltd reported a return on equity of 16.60%. Its debt-to-equity ratio is 0.87.

Company Information

Incorporated in 2007, Glen Industries Limited (GIL) is engaged in the manufacturing of eco-friendly food packaging and service products.

Website glen-india.com
Listed 15 Jul 2025
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544444.md for GLEN Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Industrial Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month